insights_auto
Why is CYAD up 6,07%?
Dive Deeperchevron_right
CYAD:EBR
Celyad Oncology SA
0,23 €
arrow_upward
+6,07%(+0,013) 1D
16-окт., 17:35:08 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYAD...
Open
0,21 €
High
0,23 €
Low
0,20 €
Mkt. cap
10,35 млн
Avg. vol.
11,20 миң
Volume
11,85 миң
P/E ratio
3,02
52-wk high
0,65 €
52-wk low
0,16 €
EPS
0,08 €
Shares outstanding
47,26 млн
No. of employees
5
Open
0,21 €
High
0,23 €
Low
0,20 €
Mkt. cap
10,35 млн
Avg. vol.
11,20 миң
Volume
11,85 миң
P/E ratio
3,02
52-wk high
0,65 €
52-wk low
0,16 €
EPS
0,08 €
Shares outstanding
47,26 млн
No. of employees
5
News stories
From web sources and news partners
StreetInsider
·
7 мүнөт мурун
GreenPower converts $2M in debentures to preferred shares for Nasdaq compliance
Yahoo Finance
·
33 мүнөт мурун
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Simply Wall Street
·
44 мүнөт мурун
Did Genetic Response Data Just Shift Madrigal Pharmaceuticals (MDGL) Investment Narrative?
Seeking Alpha
·
26 мүнөт мурун
Weekly Indicators: Long Leading Indicators Turn Neutral As AI-Centric Expansion Rolls On
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersМон-Сен-Гибер, Брабан Валон, Бельгия
Sector-
Websitecelyad.com